Accounts Payable - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41% Market Closed
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Accelerate Diagnostics Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Accelerate Diagnostics Inc
Accounts Payable Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Accelerate Diagnostics Inc
NASDAQ:AXDX
Accounts Payable
$3.8m
CAGR 3-Years
26%
CAGR 5-Years
16%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Accounts Payable
$5.4B
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
11%
Boston Scientific Corp
NYSE:BSX
Accounts Payable
$906m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
14%
Stryker Corp
NYSE:SYK
Accounts Payable
$1.3B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
Accounts Payable
$4.1B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Payable
$194.4m
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
13%

See Also

What is Accelerate Diagnostics Inc's Accounts Payable?
Accounts Payable
3.8m USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Accounts Payable amounts to 3.8m USD.

What is Accelerate Diagnostics Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
11%

Over the last year, the Accounts Payable growth was -6%. The average annual Accounts Payable growth rates for Accelerate Diagnostics Inc have been 26% over the past three years , 16% over the past five years , and 11% over the past ten years .

Back to Top